{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:39:04Z","timestamp":1790199544014,"version":"4.1.0"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Testicular cancer, predominant among young males, poses a significant healthcare challenge with varying incidence rates across European regions. Germ cell tumors (GCTs), constituting 95% of the cases, can be divided into seminoma and non-seminomatous germ cell tumors (NSGCTs). Metastases commonly occur in the lungs, lymph nodes, liver, bone, and brain. This study focuses on a 23-year-old with metastatic NSGCT, who underwent chemotherapy in an intensive care unit setting, followed by a remarkable improvement in his condition. The patient\u2019s initial complaint was persistent abdominal pain, which led to a discovery of an extensive tumor in the abdominal cavity. He underwent cytoreductive surgery, and required admission to an intensive care unit (ICU) due to surgical complications. Histopathology identified a yolk sac tumor. Despite the serious condition, chemotherapy was started. The patient\u2019s condition continued to deteriorate, requiring the initiation of mechanical ventilation. However, the multidisciplinary team opted for a continued treatment. Eventually, the AFP levels started to decrease and a gradual improvement of the patient\u2019s condition have been observed. This allowed to a bleomycin, etoposide, and platinum regimen. Following a complex hospitalization and subsequent surgical resection of residual lesions, the patient remains in good clinical condition. Regular follow-up evaluations have revealed no evidence of disease recurrence. Although NSGCT is characterized by a rather favorable prognosis, it is a significant challenge to clinicians, as the diagnosis is often delayed due to the lack or low specificity of the symptoms. Despite the usually young age of the patients diagnosed with metastatic NSGCT, the patients condition can deteriorate rapidly, presenting with multiorgan failure and a need for an ICU treatment. However, the severity of the patients\u2019 condition should not be unequivocally associated with being not suitable for a systemic curative treatment. Such patients can still benefit from the chemotherapy, and a cooperation between the oncologists and critical care physicians is crucial to improving the outcomes and increase the probability of recovery.<\/jats:p>","DOI":"10.3389\/fmed.2025.1599413","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T05:24:10Z","timestamp":1750829050000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Salvage chemotherapy in the intensive care unit: a case report of successful treatment of a critically ill patient with metastatic testicular germ cell tumor"],"prefix":"10.3389","volume":"12","author":[{"given":"Karol","family":"Grela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mykola","family":"Sobchynskyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Pi\u0229tak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Kruczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Doma\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Kucharz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Symonides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Demkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"B1","first-page":"107","author":"Giona","year":"2022","journal-title":"The epidemiology of testicular cancer."},{"key":"B2","author":"Stec","year":"2019","journal-title":"Onkologia. podr\u0229cznik dla student\u00f3w medycyny. Pomoc dydaktyczna dla lekarzy specjalizujqcych si\u0229 w onkologii."},{"key":"B3","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1159\/000444271","article-title":"Male extragonadal germ cell tumors of the adult.","volume":"39","author":"Busch","year":"2016","journal-title":"Oncol Res Treat."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.3389\/fonc.2019.01495","article-title":"Prognosis of patients with testicular carcinoma is dependent on metastatic site.","volume":"9","author":"Xu","year":"2020","journal-title":"Front Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"102367","DOI":"10.1016\/j.clgc.2025.102367","article-title":"Diagnosis, treatment and survival from testicular cancer: Real-world data from the national health service england between 2013 and 2020.","volume":"4","author":"Pang","year":"2025","journal-title":"Clin Genitourin Cancer."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1093\/annonc\/mdy217","article-title":"ESMO consensus Conference on testicular germ cell cancer: Diagnosis, treatment and follow-up.","volume":"29","author":"Honecker","year":"2018","journal-title":"Ann Oncol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1200\/JCO.1997.15.2.594","article-title":"International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers.","volume":"15","author":"Mead","year":"1997","journal-title":"J Clin Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.ejca.2005.08.043","article-title":"Survival of non-seminomatous germ cell cancer patients according to the IGCC classification: An update based on meta-analysis.","volume":"42","author":"van Dijk","year":"2006","journal-title":"Eur J Cancer."},{"key":"B9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1200\/JCO.2007.13.8461","article-title":"Randomized trial comparing bleomycin\/etoposide\/cisplatin with alternating cisplatin\/cyclophosphamide\/doxorubicin and vinblastine\/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic non-seminomatous germ cell tumors: Genito-urinary group of the french federation of cancer centers trial T93MP.","volume":"26","author":"Culine","year":"2008","journal-title":"J Clin Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s13193-016-0588-z","article-title":"Current concepts in management of stage I NSGCT.","volume":"8","author":"Ahluwalia","year":"2017","journal-title":"Indian J Surg Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.3390\/curroncol29030148","article-title":"Delivering chemotherapy to a metastatic poor risk testicular cancer patient on hemodialysis.","volume":"29","author":"Moore","year":"2022","journal-title":"Curr Oncol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1093\/annonc\/mdp598","article-title":"Proposal for dosage adjustment and timing of chemotherapy in hemodialyzed patients.","volume":"21","author":"Janus","year":"2010","journal-title":"Ann Oncol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1007\/s00277-014-2141-x","article-title":"Prognostic factors, long-term survival, and outcome of cancer patients receiving chemotherapy in the intensive care unit.","volume":"93","author":"Wohlfarth","year":"2014","journal-title":"Ann Hematol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e640","DOI":"10.1097\/CCM.0000000000002331","article-title":"Urgent chemotherapy for life-threatening complications related to solid neoplasms.","volume":"45","author":"Zerbib","year":"2017","journal-title":"Crit Care Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00520-010-0841-x","article-title":"Risk factors to predict outcome in critically ill cancer patients receiving chemotherapy in the intensive care unit.","volume":"19","author":"Song","year":"2011","journal-title":"Support Care Cancer."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1097\/01.ccm.0000181728.13354.0a","article-title":"Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy.","volume":"33","author":"Darmon","year":"2005","journal-title":"Crit Care Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13613-018-0426-2","article-title":"Characteristics and outcome of patients with newly diagnosed advanced or metastatic lung cancer admitted to intensive care units (ICUs).","volume":"8","author":"Barth","year":"2018","journal-title":"Ann Intensive Care."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1093\/annonc\/mdq019","article-title":"Low-dose induction chemotherapy with Baby-BOP in patients with metastatic germ-cell tumours does not compromise outcome: A single-centre experience.","volume":"21","author":"Gillessen","year":"2010","journal-title":"Ann Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1093\/annonc\/mdq021","article-title":"Poor prognosis non-seminomatous germ-cell tumours (NSGCTs): Should chemotherapy doses be reduced at first cycle to prevent acute respiratory distress syndrome in patients with multiple lung metastases?","volume":"21","author":"Massard","year":"2010","journal-title":"Ann Oncol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1007\/s00432-018-2695-4","article-title":"Dose-reduced first cycle of chemotherapy for prevention of life-threatening acute complications in non-seminomatous germ cell tumor patients with ultra high tumor markers and\/or poor performance status.","volume":"144","author":"Tryakin","year":"2018","journal-title":"J Cancer Res Clin Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1093\/annonc\/mdq262","article-title":"Patients with advanced non-seminomatous germ-cell tumour: The art of the start.","volume":"21","author":"Honecker","year":"2010","journal-title":"Ann Oncol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1599413\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T05:24:11Z","timestamp":1750829051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1599413\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":21,"alternative-id":["10.3389\/fmed.2025.1599413"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1599413","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]},"article-number":"1599413"}}